FBXL20 Antikörper (Middle Region)

Produktnummer ABIN926580

Der Kaninchen Polyklonal anti-FBXL20 Antikörper (ABIN926580) detektiert spezifisch FBXL20 in WB. Dieser Antikörper reagiert spezifisch mit Proben aus Human.

Kurzübersicht für FBXL20 Antikörper (Middle Region) (ABIN926580)

Target: FBXL20 (F-Box and Leucine-Rich Repeat Protein 20 (FBXL20))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser FBXL20 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Produktdetails anti-FBXL20 Antikörper

Bindungsspezifität: Middle Region

Aufreinigung: Purified

Immunogen: FBXL20 antibody was raised in rabbit using the middle region of FBXL20 as the immunogen

Anwendungsinformationen

Applikationshinweise: Optimal conditions should be determined by the investigator.

Kommentare:

FBXL20 Blocking Peptide, (ABIN939555), is also available for use as a blocking control in assays to test for specificity of this FBXL20 antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Konzentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Details zu FBXL20

Target: FBXL20 (F-Box and Leucine-Rich Repeat Protein 20 (FBXL20))

Andere Bezeichnung: FBXL20

Hintergrund: Members of the F-box protein family, such as FBXL20, are characterized by an approximately 40-amino acid F-box motif. SCF complexes, formed by SKP1, cullin, and F-box proteins, act as protein-ubiquitin ligases. F-box proteins interact with SKP1 through the F box, and they interact with ubiquitination targets through other protein interaction domains. Synonyms: Polyclonal FBXL20 antibody, Anti-FBXL20 antibody, F-box and leucine-rich repeat protein 20 antibody, FLJ21037 antibody, Fbl2 antibody, Fbl20 antibody, MGC15482 antibody, SCR antibody, SCRAPPER antibody.